CALGARY, AB / ACCESSWIRE / May 14, 2019 / CannaPharmaRx, Inc. (OTC PINK: CPMD) CannapharmaRx, Inc. (''CPMD'' or the ''Company'') is pleased to announce the strengthening of its management team via the recent hires of John Cassels as Chief Financial Officer and Andrew Steedman as Executive Vice President of Business Development. Additionally, the Board of Directors was expanded with the addition of Richard Orman and Marc Branson. As part of the management changes, Gary Herick resigned as Chief Financial Officer and Director of the Company.
John Cassels, C.A., was appointed Chief Financial Officer of the Company in April 2019. Mr. Cassels was previously the Chief Financial Officer of GN Ventures, Ltd. Prior to GN Ventures, Mr. Cassels serves as Chief Financial Officer and Vice President of Finance at Wescan Energy Corp. since May 30, 2013. Mr. Cassels served as Secretary of Northern Spirit Resources Inc. (alternate Name: Cascade Resources Inc.). He served as the Interim Chief Financial Officer at Northern Spirit Resources Inc. (alternate Name: Cascade Resources Inc.) since July 31, 2015 until September 1, 2015 and served as its Vice President of Finance. Mr. Cassels has over 35 years of experience in the Canadian natural gas and oil industry as the President and Chief Executive Officer of Paris Energy Inc., Chief Financial Officer and Vice President of Finance at Redwood Energy Ltd., Landover Energy Inc., as the Chief Executive Officer of Crown Point Energy Inc. and was a Partner of Purdy & Partners Inc. and served as its Chief Financial Officer. Mr. Cassels has served as a Director of nine small natural gas and oil companies. Mr. Cassels is a Chartered Accountant in Canada and holds a B.A. from Bishop's University in Sherbrooke, Quebec.
Andrew Steedman, was appointed Executive Vice President of Business Development of the Company in April 2019. Previously, Mr. Steedman served as an Advisor to GN Ventures, Ltd., Vice President of NXT Energy Solutions, Inc., President of Wireless Networks, Inc. and worked in Business Development for Nortel Networks, Inc. Mr. Steedman received a Bachelor of Science Degree in Electrical Engineering and a MBA both from the University of Calgary.
Marc Branson, was appointed as a director of our Company in April 2019. In addition, since January 2018 has the owner and co-founder of Titan Technologies, Inc., Vancouver, British Columbia, Canada, a development stage privately held technology company focused on AI powered block chain solutions for businesses. Since October 2016 he has also been the President and director of Catalina Gold Corp., a publicly traded Canadian company. Previously, from October 2013 through June 2015 he was President and a director of Lightning Ventures Inc., a publicly held manufacturer and distributor of specialty oil and gas products. Since 2007 he has also been President and a director of CapWest Investments., a private investment corporation that focuses on development stage companies. He received a degree in International Business from Open Learning University in 2000 and received a Business Management certificate from Capilano College in 1997.
Richard D. Orman, was appointed as a director of our Company in April 2019. In addition, he is currently the President of PLM Consultants, LTD, Calgary, Alberta, Canada, a privately held business consulting company, a position he has held since 1982. In 1986 Mr. Orman was elected to the Legislative Assembly of Alberta and was appointed to the provincial cabinet as Minister of Career Development and Employment. In 1988 he was appointed Minister of Labour. He was re-elected in 1989 and was then appointed Minster of Energy. He has over 35 years of experience with publicly traded companies in Canada, including Chairman and CEO of Kappa Energy Company, Inc., from 1994 to 2001, a director of Vanguard Oil Corp. from 1998 through 2001, and Executive Vice Chairman of Exceed Energy Company, Inc. from 2003 through 2005, Each of the aforesaid companies had their securities traded on the Toronto Stock Exchange. In addition, he was Vice Chairman of Novatel Inc., a company traded on NASDAQ from 2004 through 2007 and from 2007 through 2011 he was the lead director of Daylight Energy Ltd, also traded on the TSX. From 2015 through February 2019 he was a consultant and senior counsel at Canadian Strategy Group, a government relations firm located in Edmonton, Alberta. In 2012 he was elected to the Board of Directors and currently services as Chairman of the Board of Wescan Energy Corp. a company traded on the TSX. In 2016 he was elected and currently serves an independent non-executive director of Persta Resources, Inc., a company traded on the Hong Kong Stock Exchange. Mr. Orman received a Bachelor of Arts degree with honors from Eastern Washington University in 1971.
About CannaPharmaRx, Inc.
CannaPharmaRx is focused on the acquisition and development of state-of-the-art cannabis grow facilities located in Canada. CPMD has recently completed an initial acquisition of a 48,500 square foot cannabis grow facility presently under development and is currently in discussion with other companies regarding potential acquisitions or business combinations. CannaPharmaRx's business strategy is to become a leader in high quality and low-cost production of cannabis in Canada through the development, acquisition and enhancement of existing facilities. CannaPharmaRx is presently targeting acquisitions of companies in the final stages of obtaining cannabis licensee applications or those which are nearing revenue generation. CannaPharmaRx is committed to operating high quality facilities utilizing the latest technology in combined heat and power generation to ensure being a low-cost producer of cannabis. CannaPharmaRx is in the process of completing an application to list its common stock on the Canadian Stock Exchange with initial trading anticipated to being during the second quarter of 2019.
Safe Harbor Statement
This press release may contain forward looking statements which are based on current expectations, forecasts, and assumptions that involve risks and uncertainties that could cause actual outcomes and results to differ materially from those anticipated or expected, including statements related to the amount and timing of expected revenues and any payment of dividends on our common and preferred stock, statements related to our financial performance, expected income, distributions, and future growth for upcoming quarterly and annual periods. These risks and uncertainties are further defined in filings and reports by the Company with the U.S. Securities and Exchange Commission (SEC). Actual results and the timing of certain events could differ materially from those projected in or contemplated by the forward-looking statements due to a number of factors detailed from time to time in our filings with the Securities and Exchange Commission. Among other matters, CannaPharmaRx, Inc. may not be able to sustain growth or achieve profitability based upon many factors including, but not limited to, general stock market conditions. Reference is hereby made to cautionary statements set forth in the company's most recent SEC filings. We have incurred and will continue to incur significant expenses in our expansion of our existing and new service lines, noting there is no assurance that we will generate enough revenues to offset those costs in both the near and long term. Additional service offerings may expose us to additional legal and regulatory costs and unknown exposure(s) based upon the various geopolitical locations where we will be providing services, the impact of which cannot be predicted at this time.
Attention [email protected]
SOURCE: CannaPharmaRx, Inc.